Hospitalization from COVID-19 is most frequently observed in patients with atopic dermatitis treated with systemic corticosteroids, and in particular when systemic corticosteroids are used in combination with another immunomodulatory treatment: lessons from the global SECURE-AD registry

Broderick, C.; Musters, A. H.; Prieto-Merino, D.; Arents, B.; Burton, T.; Bosma, A. L.; Chi, C. C.; Fletcher, G.; Drucker, A. M.; Kabashima, K.; Wall, D.; Irvine, A. D.; Spuls, P.; Flohr, C.

Broderick, C.; Musters, A. H.; Prieto-Merino, D.; Arents, B.; Burton, T.; Bosma, A. L.; Chi, C. C.; Fletcher, G.; Drucker, A. M.; Kabashima, K.; Wall, D.; Irvine, A. D.; Spuls, P.; Flohr, C..

BRITISH JOURNAL OF DERMATOLOGY ; 187:16-17, 2022.

Article in English | Web of Science | ID: covidwho-1935133

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Language: English Journal: BRITISH JOURNAL OF DERMATOLOGY Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Language: English Journal: BRITISH JOURNAL OF DERMATOLOGY Year: 2022 Document Type: Article